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The availability and interactions of signaling proteins are tightly
regulated in time and space to produce specific and localized
effects. For calmodulin (CaM), a key transducer of intracellular Ca2
signaling, binding to its variety of targets initiates signaling cas-
cades and regulates its subcellular localization, thereby making it
unavailable for subsequent binding interactions. Among CaM’s
numerous targets, Ca2CaM-dependent protein kinase II is one of
the most striking due to its unique ability to increase its affinity for
CaM by autophosphorylation and to translocate when bound to
Ca2CaM. Two-photon fluorescence correlation spectroscopy and
cross-correlation spectroscopy were utilized to compare mobility
and molecular interactions between CaM and Ca2CaM-depen-
dent protein kinase II in solution and in living cells. These tech-
niques revealed that CaM availability in cells could be altered by a
change in intracellular conditions. Two-photon fluorescence cross-
correlation spectroscopy exemplifies a generally applicable ap-
proach for studying protein–protein interactions in living cells that
allows access to the behavior of signaling molecules within their
native environment to probe for heterogeneities in signaling
pathways in different cellular compartments.
Intracellular signal transduction is an elegant process of infor-mation transfer through rapid and precise biochemical inter-
actions. The historic concept where receptors and other signaling
proteins remain in place while spatial signal transmission is
proliferated by the rapid diffusion of second messengers can no
longer completely describe all types of signaling (1). Instead, a
more dynamic bidirectional scenario emerges where either the
protein goes to the signal, or the signal comes to the protein,
or both. One such mechanism is the targeted colocalization of
interacting signaling proteins for the selective activation of
downstream processes (1, 2). These localization mechanisms can
be highly regulated and rapidly reversible.
The Ca2-calmodulin (CaM) pathway is an ideal illustration of
this paradigm shift. CaM binds four Ca2 ions, exposing sites that
lead to target binding. An assumption of many models of
CaM-dependent regulation has been that a large pool of intra-
cellular CaM is freely diffusible. Based on this assumption,
CaM-dependent function would strictly depend on transient
Ca2 signals as the rate-limiting step in enzyme activation. The
idea of compartmentalization and limiting concentrations of
CaM depicts a different scenario where competition among
multiple CaM-binding proteins for limited CaM would ulti-
mately determine the profile of CaM-dependent enzyme acti-
vation (3–6). Ca2CaM-dependent protein kinase II (CaM-
kinase II) is the most concentrated CaM-dependent enzyme in
nerve cells. It also has the unique ability to increase its affinity
for CaM by several orders of magnitude by autophosphorylation
(7, 8). In cells where CaM-kinase II is abundant, such as
hippocampal neurons, this characteristic may act as a mechanism
to modulate other CaM-dependent processes by sequestering
CaM onto CaM-kinase II, making it unavailable for the activa-
tion of other enzymes.
Details of earlier models for CaM-dependent regulation were
based solely on studies of CaM and its target enzymes in dilute
solution. However, the intracellular milieu is considerably more
complex where constraints on diffusion may be imposed by
factors, such as macromolecular crowding and cytoskeletal ele-
ments, that could make some compartments unavailable or even
promote intermolecular associations not favored in dilute solu-
tions (9–11). Therefore, CaM availability must be determined
empirically in cells and cannot be directly extrapolated from
experiments using purified proteins.
Here we use two-photon cross-correlation spectroscopy
[TPCCS; (12, 13)] to analyze the dynamics of protein–protein
interactions of CaM and CaM-kinase II down to the single-
molecule level both in solution and in living cells. The use of
these techniques revealed that CaM availability in cells can be
altered by a change in intracellular conditions, and that CaM
availability can be modulated by protein–protein interactions.
Materials and Methods
Mutagenesis, Expression, and Purification of CaM. The CaM expres-
sion plasmid pCR2 was generously provided by Carol Rohl
(University of California, Santa Cruz) and Rachel Klevit (Uni-
versity of Washington, Seattle). Introduction of a single Cys
residue by conversion of Asp at amino acid 3 to Cys to produce
CaM(C3) was accomplished with the QuikChange Site-Directed
Mutagenesis Kit (Stratagene). The presence of the desired
mutation and the absence of artifacts were verified by DNA
sequencing. BL21(DE3)plysS (Novagen) cells expressing CaM
were grown and harvested, and recombinant CaM was purified
as described (14) with minor modifications, dialyzed into 50 mM
Mops, pH 7.0, and stored at 20°C. CaM was quantified by a
modified Bradford protein assay (Bio-Rad) and was homoge-
neous as judged by SDSPAGE.
Labeling of CaM(C3) with Alexa 633. CaM labeling was performed
as described (8) with the following modifications. CaM(C3) was
reduced with dithiothreitol; Alexa 633 maleimide (Molecular
Probes) was dissolved in DMSO and added in 6.5-fold molar
excess over both protein and dithiothreitol. The reaction was
allowed to proceed overnight at 4°C and was quenched by using
10 mM 2-mercaptoethanol. The labeled protein was purified by
using a 15-cm Bio-Gel P6-DG (Bio-Rad) column and eluted with
50 mM Hepes, pH 7.0. Based on Alexa633  100,000(Mcm) at
622 nm (Molecular Probes), probe-to-protein ratios were deter-
mined to be 0.9 for the labeled protein. Full characterization
of the fluorescently labeled protein was done to determine its
ability to activate CaM-kinase II and its spectral properties over
a physiological range of parameters, such as pH, Ca2 concen-
tration, and ionic strength (unpublished work).
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Construction, Expression, and Purification of eGFP-CaM-Kinase II. A
eukaryotic expression plasmid for enhanced GFP (eGFP) CaM-
kinase II was generated by subcloning a rat CaMKII cDNA into
the pEGFP-C2 vector (Clontech). The eGFP-CaM-kinase II
construct was sequenced to verify that no undesired mutations
were present. The eGFP-CaM-kinase II construct created above
was subcloned into the pFastBac1 baculovirus expression vector
(GIBCOInvitrogen), and recombinant eGFP-CaM-kinase II
was produced by using the baculovirus expression system and
purified as described (8) to near homogeneity. A full character-
ization of eGFP-CaM-kinase II showed that the protein was a
holoenzyme and possessed similar specific activity and minimal
basal independent activity as wild-type enzyme (S.A.K. and
M.N.W., unpublished observation). Purified eGFP-CaM-kinase
II preparations were stored at 80°C.
Preparation of Reactions in Solution for Two-Photon Fluorescence
Correlation Spectroscopy (TPFCS) and TPCCS Measurements. Purified
eGFP-CaM-kinase II samples were spun in a microfuge at 110 
g for 30 min at 4°C to remove particulate material after thawing.
All solutions were prepared in a low-fluorescence HPLC grade
water (Merck Sharp & Dohme) and were filter sterilized.
Twenty-four-microwell chambers (Evotec OAI, Hamburg, Ger-
many) were preincubated with 10% BSA for 10 min followed by
two subsequent washes with an enzyme dilution buffer (25 mM
Hepes, pH 7.0150 mM KCl 0.1 mgml BSA). Reaction condi-
tions for cross-correlation measurements included: Alexa
633(C3)CaM and eGFP-CaMKII in 25 mM Hepes, pH 7.0; 100
mM KCl, 10 mM Mg2 with 0.5 mM CaCl2; and 1 mM MgATP
(Amersham Pharmacia) followed by 1 mM EGTA. Each reac-
tion was well mixed prior to each measurement, and measure-
ments were performed at room temperature.
Cell Culture. Human embryonic kidney 293 (HEK293) cells were
kindly provided by Ralf Nehring and Andreas Karschin (Max
Planck Institute for Biophysical Chemistry) and were originally
obtained from American Type Culture Collection (CRL-1573).
HEK293 cells were maintained in DMEM supplemented with
10% heat-inactivated fetal bovine serum and 100 unitsml
penicillin and 100 unitsml streptomycin in a humidified incu-
bator containing 5% CO2 at 37°C. Cells were plated at a density
of 250,000 cells per dish on poly-D-lysine-(0.01 mgml) coated
MatTek dishes (MatTek, Ashland, MA) and used 24–48 h after
plating. To minimize autofluorescence, HEK293 cells were
plated in phenol red-free media prior to experiments.
Transfection and Making of Stable Cell Lines. HEK293 cells were
transfected with eGFP-CaM-kinase II using Effectene (Qiagen,
Hilden, Germany) as described by the manufacturer. Cells were
passaged into selective medium containing 1,000 unitsml G418
(GIBCOBRLInvitrogen) 3 d posttransfection and maintained
under selection for at least 3 wk prior to use. Approximately 50%
of the population was positive for eGFP-CaM-kinase II expres-
sion in a nanomoler concentration range.
Electroporation. Alexa 633-labeled CaM at amino acid 3 (Cys)
[Alexa 633(C3)CaM] was introduced into adherent cells based
on a technique developed by Teruel et al. (15). Electroporation
was performed at 150–250 Vcm by using three rectangular
voltage pulses, each 50 ms long and 1 min apart (BTX, Holliston,
MA) in electroporation buffer (125 mM NaCl5 mM KCl1.5
mM MgCl220 mM Hepes10 mM glucose, pH 7.4). Prior to
experiments, cells were allowed to recover for at least 1 h.
Conditions for Cellular Imaging and Spectroscopy Measurements.
During all experiments, cells were incubated at room tempera-
ture in a Hepes-buffered saline solution (HBSS) containing: 116
mM NaCl; 5.4 mM KCl; 0.8 mM MgSO4; 1.6 mM CaCl2; 20 mM
Hepes; and 10 mM glucose, pH 7.4 (16). For some experiments,
cells were incubated in one of the following conditions: HBSS
with no added Ca2, 15 gml -hemolysin (-toxin; Sigma),
and 200 M EGTA (Ca2-free); or HBSS with 15 gml
-hemolysin, 10 mM CaCl2, and 1 mM MgATP (elevated Ca2).
-Hemolysin permeabilizes the cell membrane, allowing rapid
equilibrium of extracellular ions and nucleotides with the intra-
cellular environment. HEK293 cells were prepared in parallel for
spectroscopy measurements and Ca2 imaging. Fluo-4 was used
to confirm that Ca2 was being elevated or decreased uniformly
in all cells under the different conditions.
TPCCS Setup. TPFCS and TPCCS measurements were achieved
by using a tunable mode-locked titanium:sapphire laser (Tsu-
nami, Spectra-Physics), operating at 80 MHz with 100-fs pulses,
coupled to an inverted Olympus (Melville, NY) IX50 micro-
scope (12). A 5 Galilean beam expander (coated for the
near-IR spectral range; Thorlabs, Newton, NJ) ensured proper
overfilling of the back aperture of the water immersion objective
(Uplan-ApoIR 60, numerical aperture 1.2, Olympus), creat-
ing a diffraction-limited focal spot. Determined from calibration
measurements of Rhodamine green (Molecular Probes), a radial
dimension (r0) of 0.35 m and an axial dimension (z0) of 0.95 m
with an effective volume element of 0.22 fl were used to
describe the two-photon focal volume. The sample was excited
with a single laser line at 920 nm. Fluorescence was separated
from the excitation light path by the first dichroic mirror
(750DCSP, AHF Analysentechnik, Tu¨bingen, Germany) with a
bandpass emission filter 600DF200 (AHF) for efficient suppres-
sion of IR excitation light. The emitted light was collimated and
then split by a second longpass dichroic mirror 615LP (AHF).
Additional detection light specificity was obtained by a 52570M
(AHF) bandpass filter in the eGFP and 680100 (AHF) band-
pass filter in the Alexa 633 detection channels. Two optical fiber
coupled avalanche photodiodes SPCM-200 (Perkin–Elmer)
were used for detection. The optical fibers (Thorlabs) with a
diameter of 100 m were separately adjustable in the x, y, and
z directions. The digital pulses of the avalanche photodiodes
were amplified, split, and simultaneously correlated online by
two personal computer ALV-5000 multiple  correlator cards
(ALV-Laser, Langen, Germany), one operating in a dual auto-
correlation, and the other operating in a cross-correlation mode.
For single-color measurements, the second dichroic mirror
(615LP) was removed. Evaluation of the curves was accom-
plished by using ORIGIN (MicroCal Software, Northampton,
MA) with a Levenberg–Marquardt nonlinear least-squares fit-
ting routine.
Spectra for eGFP [Fig. 1b(1) and Alexa 633, Fig. 1b(2)] were
taken by using a fiber-coupled spectrometer (Ocean Optics,
Dunedin, IL) with fiber diameter of 100m. Two-photon excited
spectra were measured from micromolar dye solutions within the
focal volume element at 920 nm. The transmission characteristics
of the dichroic mirror [Fig. 1b(3)] and filters [Fig. 1b(4) and (5)]
used for spectral separation of the emission light are also plotted.
Optimal measurement conditions for these experiments were
determined and will be discussed elsewhere (unpublished
observations).
Theoretical Concept TPFCS and TPCCS. The technique of fluores-
cence correlation spectroscopy measures mobility and chemical
kinetics of fluorescent molecules (17) by autocorrelation analysis
of time-resolved fluorescence intensity f luctuations, F(t), col-
lected from a small group of diffusing molecules (typically
nanomolar concentrations). At equilibrium, the number of flu-
orescent molecules within a small probe volume fluctuates about
a mean value due to individual molecules diffusing in and out of
the volume. The deviations from the mean in the measured
fluorescence are correlated as G(), which is generally given by:





where the indices refer to one or two measured fluorescence
signals, Fr andor Fg. In the case of one fluorescent species
[Alexa 633(C3)CaM or eGFP-CaM-kinase II alone], Eq. 1 (r 
g) defines the normalized fluorescence autocorrelation function
in a single detection channel.
The autocorrelation function decays with time . The shape of
the decay and characteristic decay time are related to the
mechanisms and rates of the processes that generate the fluo-
rescence fluctuations. The amplitude of the autocorrelation
function is inversely proportional to the number of fluorescent
particles in the volume element.
For the simplest case (i.e., dye or protein in solution), in a
system of one fluorescent species undergoing Brownian motion
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where r0 and z0 are the half-axes of the detection volume,
assumed to have a Gaussian shape; N is the average number of
molecules in the detection volume; and D is average lateral
transit time of the molecules through the focus (D  r0
28D for
two-photon excitation, where D is the diffusion coefficient). By
calibrating the detection volume with a solution of freely dif-
fusing dye molecules with known diffusion properties, a diffusion
coefficient of the probe of interest can be calculated from
empirically determined diffusion times, D. For intracellular
measurements, a two-diffusing species model was used by fitting
to a weighted sum of two terms in Eq. 2.
Cross-correlation, an extension of FCS using two spectrally
distinct f luorophores, analyzes molecular interactions of differ-
ent molecules (see refs. 18 and 19 for a more detailed discussion
of the theory and formalism of cross-correlation analysis). For
this type of analysis, f luorescence fluctuations of two different
fluorescent molecules [(r 
 g) in Eq. 1, Alexa 633(C3)CaM and
eGFP-CaM-kinase II] are simultaneously recorded and cross-
correlated. Grg defines the cross-correlation function, which
compares the fluorescence signals of different species for dif-
ferent lag times . Under ideal conditions with minimal spectral
crosstalk between the dyes and in the absence of fluorescence
resonance energy transfer, the amplitude Grg(0) is directly
proportional to the relative concentration of bound species. The
absolute concentration can be derived from the corresponding
autocorrelation curves.
An excess of Alexa 633(C3)CaM was always maintained for in
vitro reactions to favor binding. The binding of eGFP-CaM-








where Crg	  Grg(0)[Veff(Gr(0)Gg(0))], Cg	  1[VeffGg
(0)], and Veff is the effective detection volume. In the case of no
binding, Grg(0) equals zero.
Results
Intracellular Mobility of CaM. Autocorrelation curves of Alexa
633(C3)CaM were measured in HEK293 cells stably transfected
with eGFP-CaM-kinase II under Ca2-free or elevated Ca2
Fig. 1. Setting up TPCCS. (a) The optical setup is based on an inverted
Olympus IX50 microscope. A single Ti:Sa laser line illuminates the sample; the
detected light is split by a dichroic mirror behind the collimating lens and
focused onto two different optical fiber-coupled detectors [single-photon
avalanche diodes (SPADs)]. The signals are correlated online by a personal
computer correlator card. (b) Normalized fluorescence emission spectra of the
two-photon excited dye system measured within the focal spot by a fiber-
coupled spectrometer. Excitation wavelength is 920 nm for both eGFP (trace
1) and Alexa 633 (trace 2). Very little overlap is seen between the two emission
spectra, and the dichroic mirror (trace 3, 615LP), coupled to the emission filters
(trace 4, eGFP), 52570M; and (trace 5, Alexa 633, 680100), cleanly separates
the signal for excellent discrimination between the two channels.
Fig. 2. Inducing alterations in intracellular diffusion of Alexa 633(C3)CaM.
Autocorrelation curves (normalized) were measured in HEK293 cells stably
transfected with eGFP-CaM-kinase II under Ca2-free (200 M EGTA) or
elevated Ca2 (10 mM Ca21 mM MgATP) conditions in the presence of 15g
of -hemolysin. A large change in mobility of Alexa 633(C3)CaM is seen in
elevated Ca2. The d values reported (Inset) are based on a two-component
model (see Materials and Methods).







conditions in the presence of 15 g of -hemolysin (used for cell
permeabilization to elevate intracellular Ca2 and MgATP).
Qualitatively, the half-maximal value of the curve reflects the
approximate diffusion time of the Alexa 633(C3)CaM (molec-
ular mass 17 kDa), and a right shift in an FCS curve indicates
a slower diffusing species. For changes in diffusion to be
detected, CaM must be bound to molecules of significantly larger
size, because diffusion time varies with the inverse cube root of
the molecular mass.
In the Ca2-free condition, the majority of Alexa 633(C3)CaM
(72.0%) is found to be freely diffusing (d  0.73 ms, see Fig. 2
Inset) in the HEK293 cell, with the remainder (28.0%) diffusing
very slowly (d  15.5 ms, see Fig. 2 Inset). The 3-fold slower
intracellular diffusion of CaM (d  0.73 ms, see Fig. 2 Inset)
compared with in-solution measurements (d  0.25 ms; see Fig.
3) can be attributed to increased cellular viscosity (20). The slow
component is most likely an average of different bound popu-
lations of Alexa 633(C3)CaM, because it is poorly resolved under
these measurement conditions. Elevating Ca2 produced a large
change in the intracellular diffusion of Alexa 633(C3)CaM (Fig.
2; 2-fold decrease in the rate of diffusion of the faster component
in a two-component fit) in the presence of eGFP-CaM-kinase II
[12 subunits (21) with a total 984 kDa]. Not only was there a
decrease in the mobility of Alexa 633(C3)CaM, but also the
fractions of the two components shifted to an equal distribution
between the two different populations in the elevated Ca2
condition. As indicated by the mobility, this suggests that a
change in intracellular Ca2 concentration can alter the avail-
ability of CaM and perhaps ultimately the profile of CaM-
dependent activation.
Assessment of Binding Between CaM and CaM-Kinase II in Solution by
Using TPCCS. Although a change in diffusion of CaM, in the
presence of added binding sites (CaM-kinase II, Fig. 2), indicates
an alteration of the availability of CaM, it does not directly
specify the cause for the change. Therefore, we utilized cross-
Fig. 3. Binding reactions of Alexa 633(C3)CaM and eGFP-CaM-kinase II assessed with TPCCS in solution. The central schematic depicts molecules of Alexa
633(C3)CaM and eGFP-CaM-kinase II diffusing through the focal volume, giving rise to the fluorescent signals in the green and red channels (a). Only
eGFP-CaM-kinase II having at least one Alexa 633(C3)CaM bound to it appears in both channels simultaneously and contributes to the cross-correlation amplitude
(coincident green and red signals in middle of a). Normalized cross-correlation curves show the extent of binding in two different conditions in the presence of
0.5 mM Ca21 mM MgATP (light blue) and 1 mM EGTA (dark blue) (b). The corresponding autocorrelation [green, eGFP-CaM-kinase II; red, Alexa 633(C3)CaM]
and cross-correlation (Lower, broken red–green curve) curves are also provided for the two conditions in c and d.
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correlation to investigate binding interactions between CaM and
CaM-kinase II. An extension of the standard FCS scheme,
TPCCS is a sensitive tool to follow the association or dissociation
of different molecules.
In the central schematic of Fig. 3, both bound and unbound
Alexa 633(C3)CaM and eGFP-CaM-kinase II (shown here as a
monomer for clarity) are depicted diffusing through the focal
volume, giving rise to the fluorescent signals in the green and red
channels (Fig. 3a, seen as schematic fluorescence fluctuations).
Red CaMs, both free and bound to CaM-kinase II, contribute to
the red CaM autocorrelation curve (red curves in Fig. 3 c and d),
whereas green CaM-kinase IIs with and without red CaM bound
contribute to the green autocorrelation curve (green curves in
Fig. 3 c and d). However, only green CaM-kinase IIs having at
least one red CaM bound to it appear in both channels simul-
taneously (coincident green and red signals in middle of Fig. 3a)
and contribute to the cross-correlation amplitude (broken red–
green line in Fig. 3d).
The cross-correlation amplitude (bound CaM-kinase II and
CaM) relates to the red CaM autocorrelation amplitude as the
number of bound molecules to the total number of green
CaM-kinase II in the system (Eq. 3; Fig. 3 c Lower and d Lower;
red curves indicate Alexa 633(C3)CaM autocorrelation, and
broken red–green lines show cross-correlation). The greater the
fraction of bound Ca2-CaM–CaM-kinase II complexes, the
higher the cross-correlation amplitude relative to the red auto-
correlation amplitude (Fig. 3d Lower). Because the nonnormal-
ized cross-correlation amplitude is the same height as the red
autocorrelation curve for CaM, almost all green CaM-kinase II
molecules observed must have at least one bound red CaM.
Several types of information (Table 1) can be culled from
these data, including: concentrations of each of the interacting
molecules, absolute ratios of the average molecules, extent of
binding, and the diffusion of each of the molecules involved.
These data is tabulated in Table 1 for the experiment described
in Fig. 3. In this particular reaction, increased binding (95%) was
seen in the presence of 0.5 mM Ca21 mM MgATP; subse-
quently, 1 mM EGTA (causing only minimal dilution) was added
to the same reaction to show the reversal of the binding (Fig. 3b).
This resulted in reduced cross correlation (12%) due to the
dissociation of CaM from CaM-kinase II. Negative control
reaction of Alexa 633 hydrazide and CaM-kinase II (data not
shown) under all conditions showed 8–12% cross correlation,
indicating that the 11.5% of binding is nonspecific.
Monitoring Intracellular CaM and CaM-Kinase II Binding Dynamics.
Historically, colocalization of two molecules was used as a
method for estimating possible interactions between proteins.
Confocal laser scanning images of stably transfected eGFP-
CaM-kinase II HEK293 cells electroporated with Alexa
633(C3)CaM show little noticeable difference in their distribu-
tion in the presence of elevated Ca2 (Fig. 4a) or Ca2-free (Fig.
4b) conditions. In both images, Alexa 633(C3)CaM was localized
to the cytosol with a higher concentration in the nucleus,
whereas eGFP-CaM-kinase II was generally cytoplasmic with
very little signal in the nucleus. Although the molecules were
colocalized in the cytoplasm in both conditions, analysis using
TPCCS shows quite different binding dynamics.
Cross-correlation curves were measured in the living cell
under elevated Ca2 followed by Ca2-free conditions in the
same dish, and curves were calibrated to the autocorrelation of
Alexa 633(C3)CaM (Fig. 2b) that were collected simultaneously.
Increases of intracellular [Ca2] and [ATP] (with -hemolysin to
provide optimal conditions for maximal intracellular binding)
increased the binding interaction in a predictable manner. The
amplitude of the cross-correlation, corresponding to the binding
efficiency, increased with elevated Ca2 (light blue) and de-
creased with Ca2-free conditions (dark blue; Fig. 4c). Experi-
mentally, we find no evidence of binding in cells after they were
bathed in Ca2-free conditions.
Discussion
We successfully show the proof of the principle utilizing TPCCS
to study the reversible binding dynamics of Alexa 633(C3)CaM
and eGFP-CaM-kinase II both in solution and in the living cell.
TPCCS provides a sensitive method for measuring protein–
protein interactions and offers a complementary approach to the
popular technique of fluorescence resonance energy transfer.
TPCCS as applied in the present study exploits the technical and
biological advantages of two-photon excitation to optimize cross
correlation. Two-photon excitation confers the ability to simul-
taneously excite multiple dyes with a single laser line and
Fig. 4. Intracellular changes of binding of Alexa 633(C3)CaM and eGFP-CaM-
kinase II. Confocal images of stably transfected eGFP-CaM-kinase II HEK293
cell line electroporated with Alexa633(C3)CaM show little change in appear-
ance under 10 mM Ca21 mM MgATP (a) followed by 200 M EGTA (b)
conditions in the presence of 15 gml -hemolysin in the same dish. Intra-
cellular cross-correlation curves (normalized) were measured under each of
the conditions. The amplitude of the cross-correlation, corresponding to the
binding efficiency, increased with elevated Ca2MgATP (light blue) and
decreased with no Ca2 (dark blue). (Bar  10 m.)










Ratio of molecules of
CaMKII to total CaM
1:42 1:36
Binding efficiency 12 95
Summary of the calculated values from the analysis of autocorrelation [Fig.
3 c and d; green, eGFP-CaM-kinase II; red, Alexa 633(C3)CaM] and cross-
correlation (Fig. 3 c Lower and d Lower, broken red–green curve) curves
including the observed ratio between the two molecules, extent of binding,
concentrations, and diffusion of each of the interacting molecules in the
presence of 1 mM EGTA (Fig. 3c, dark blue) and 0.5 mM Ca21 mM MgATP
(Fig. 3d, light blue).







requires no pinholes for detection, minimizing optical alignment
issues and guaranteeing overlap of the excitation volumes. In
addition to the general advantages for cellular applications of
inherent optical sectioning, two-photon excitation reduces cu-
mulative photobleaching, which can artificially decrease the
cross-correlation amplitude. Thus, TPCCS allows access to
studying protein–protein interactions of signaling molecules
within their native environment and was specifically used here
for the assessment of CaM-binding to CaM-kinase II inside living
cells.
CaM-kinase II is a large dodecameric molecule with 12
potential binding sites for CaM that has the ability to modulate
its own CaM-binding affinity when activated by Ca2-saturated
CaM (7, 8). Coupled with its particularly high concentrations in
certain cells (22), these observations led to the proposal that a
potential role for CaM-kinase II may be to modulate CaM
availability for other CaM-dependent processes (7, 8, 23). The
autocorrelation curves presented in Fig. 2 provide experimental
in situ evidence for this hypothesis. In HEK-293 cells transfected
with CaM-kinase II, conditions of elevated Ca2 and MgATP
produced significant (2.2-fold) slowing of CaM diffusion. How-
ever, standard one-color FCS suffers from the ambiguity that a
slowed CaM diffusion can be attributed to environmental ef-
fects, such as different local viscosities or nonspecific interac-
tions, rather than specific binding to CaM-kinase II. We there-
fore applied TPCCS to directly assess CaM and CaM-kinase II
interactions in vitro and subsequently in situ. The optimal
conditions for measuring TPCCS data were established in vitro
by using purified eGFP-tagged CaM-kinase II and Alexa 633-
labeled CaM. As anticipated, these data revealed that in the
presence of Ca2 and MgATP, the binding efficiency between
CaM and CaM-kinase II increased dramatically from 12% (same
as negative control) to 95%. By applying TPCCS to the HEK cell
model, it was possible to establish that one cause of the slowed
CaM diffusion was directly due to its interactions with CaM-
kinase II under elevated Ca2 and MgATP conditions. In total,
our data experimentally support the hypothesis that intracellular
CaM availability, and therefore activation of the entire family
of CaM-dependent enzymes, can be regulated by the presence of
CaM-kinase II. We generally conclude that the combination
of TPFCS and TPCCS is feasible, and both, when combined, are
powerful techniques to assess the interactions of signaling
molecules in vitro and inside living cells.
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